{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:52:54Z","timestamp":1767034374583,"version":"3.40.4"},"reference-count":38,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1254\/jphs.13172fp","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T23:01:25Z","timestamp":1387580485000},"page":"47-53","source":"Crossref","is-referenced-by-count":11,"title":["Possible Involvement of Endogenous Opioid System Located Downstream of \u03b17 Nicotinic Acetylcholine Receptor in Mice With Physical Dependence on Nicotine"],"prefix":"10.1254","volume":"124","author":[{"given":"Keiko","family":"Ueno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Kiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Saika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Wakida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiroh","family":"Kishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry. 1991;48:52\u201359.","DOI":"10.1001\/archpsyc.1991.01810250054007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Williams JM, Steinberg MB, Steinberg ML, Gandhi KK, Ulpe R, Foulds J. Varenicline for tobacco dependence: panacea or plight? Expert Opin Pharmacother. 2011;12:1799\u20131812.","DOI":"10.1517\/14656566.2011.587121"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Beard E, Michie S, Fidler J, West R. Use of nicotine replacement therapy in situations involving temporary abstinence from smoking: a national survey of English smokers. Addict Behav. 2013;38:1876\u20131879.","DOI":"10.1016\/j.addbeh.2012.09.013"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Clarke PB, Reuben M. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br J Pharmacol. 1996;117:595\u2013606.","DOI":"10.1111\/j.1476-5381.1996.tb15232.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 1996;382:255\u2013257.","DOI":"10.1038\/382255a0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wilkie GI, Hutson PH, Stephens MW, Whiting P, Wonnacott S. Hippocampal nicotinic autoreceptors modulate acetylcholine release. Biochem Soc Trans. 1993;21:429\u2013431.","DOI":"10.1042\/bst0210429"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 1995;269:1692\u20131696.","DOI":"10.1126\/science.7569895"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Yang X, Criswell HE, Breese GR. Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. J Pharmacol Exp Ther. 1996;276:482\u2013489.","DOI":"10.1016\/S0022-3565(25)12298-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Boyadjieva NI, Sarkar DK. The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. Life Sci. 1997;61:PL59\u2013PL66.","DOI":"10.1016\/S0024-3205(97)00444-X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kiguchi N, Maeda T, Tsuruga M, Yamamoto A, Yamamoto C, Ozaki M, et al. Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice. Brain Res. 2008;1189:70\u201377.","DOI":"10.1016\/j.brainres.2007.10.086"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Isola R, Zhang H, Tejwani GA, Neff NH, Hadjiconstantinou M. Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum. Psychopharmacology. 2009;201:507\u2013516.","DOI":"10.1007\/s00213-008-1315-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Gudehithlu KP, Duchemin AM, Tejwani GA, Neff NH, Hadjiconstantinou M. Nicotine-induced changes of brain <i>\u03b2<\/i>-endorphin. Neuropeptides. 2012;46:125\u2013131.","DOI":"10.1016\/j.npep.2012.03.001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Vincler M. Neuronal nicotinic receptors as targets for novel analgesics. Expert Opin Investig Drugs. 2005;14:1191\u20131198.","DOI":"10.1517\/13543784.14.10.1191"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Campbell VC, Taylor RE, Tizabi Y. Antinociceptive effects of alcohol and nicotine: involvement of the opioid system. Brain Res. 2006;1097:71\u201377.","DOI":"10.1016\/j.brainres.2006.04.054"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Yamamoto A, Kiguchi N, Kobayashi Y, Maeda T, Ueno K, Yamamoto C, et al. Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation. Life Sci. 2011;89:956\u2013961.","DOI":"10.1016\/j.lfs.2011.10.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Mellon RD, Bayer BM. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. J Pharmacol Exp Ther. 1999;288:635\u2013462.","DOI":"10.1016\/S0022-3565(24)38000-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Armario A. Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci. 2010;31:318\u2013325.","DOI":"10.1016\/j.tips.2010.04.005"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci. 2006;27:482\u2013491.","DOI":"10.1016\/j.tips.2006.07.004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, L\u00e9na C, Le Nov\u00e8re N, de Kerchove d\u2019Exaerde A, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999;398:805\u2013810.","DOI":"10.1038\/19756"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Damaj MI, Meyer EM, Martin BR. The antinociceptive effects of <i>\u03b1<\/i>7 nicotinic agonists in an acute pain model. Neuropharmacology. 2000;39:2785\u20132791.","DOI":"10.1016\/S0028-3908(00)00139-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Abdin MJ, Morioka N, Morita K, Kitayama T, Kitayama S, Nakashima T, et al. Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord. Life Sci. 2006;80:9\u201316.","DOI":"10.1016\/j.lfs.2006.08.011"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Berrendero F, Kieffer BL, Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci. 2002;22:10935\u201310940.","DOI":"10.1523\/JNEUROSCI.22-24-10935.2002"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Berrendero F, Mendiz\u00e1bal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, et al. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci. 2005;25:1103\u20131112.","DOI":"10.1523\/JNEUROSCI.3008-04.2005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Zenkar N, Bernstein DE. The estimation of small amounts of corticosterone in rat plasma. J Biol Chem. 1958;231:695\u2013701.","DOI":"10.1016\/S0021-9258(18)70434-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Malin DH. Nicotine dependence: studies with a laboratory model. Pharmacol Biochem Behav. 2001;70:551\u2013559.","DOI":"10.1016\/S0091-3057(01)00699-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Kishioka S, Nishida S, Fukunaga Y, Yamamoto H. Quantitative properties of plasma corticosterone elevation induced by naloxone-precipitated withdrawal in morphine-dependent rats. Jpn J Pharmacol. 1994;66:257\u2013263.","DOI":"10.1254\/jjp.66.257"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ueno K, Maeda T, Kiguchi N, Kobayashi Y, Ozaki M, Kishioka S. Availability of serum corticosterone level for quantitative evaluation of morphine withdrawal in mice. Drug Discov Ther. 2011;5:71\u201375.","DOI":"10.5582\/ddt.2011.v5.2.71"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Laorden ML, Fuertes G, Gonz\u00e1lez-Cuello A, Milan\u00e9s MV. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of <i>\u03b1<\/i><sub>1<\/sub>- and <i>\u03b1<\/i><sub>2<\/sub>-adrenoceptors. J Pharmacol Exp Ther. 2000;293:578\u2013584.","DOI":"10.1016\/S0022-3565(24)39271-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Nunez C, F\u00f6ldes A, Laorden ML, Milanes MV, Kov\u00e1cs KJ. Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J Neurochem. 2007;101:1060\u20131071.","DOI":"10.1111\/j.1471-4159.2006.04421.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Mart\u00edn F, Laorden ML, Milan\u00e9s MV. Morphine withdrawal regulates phosphorylation of cAMP response element binding protein (CREB) through PKC in the nucleus tractus solitarius-A2 catecholaminergic neurons. J Neurochem. 2009;110:1422\u20131432.","DOI":"10.1111\/j.1471-4159.2009.06234.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Kishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, et al. Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice. Neurosci Lett. 2013;552:98\u2013102.","DOI":"10.1016\/j.neulet.2013.07.040"},{"key":"32","unstructured":"32 Bia\u0142a G, Budzy\u0144ska B, Kruk M. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. Pharmacol Rep. 2005;57:755\u2013760."},{"key":"33","unstructured":"33 Lee MC, Wagner HN Jr, Tanada S, Frost JJ, Bice AN, Dannals RF. Duration of occupancy of opiate receptors by naltrexone. J Nucl Med. 1988;29:1207\u20131211."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Ngai SH, Berkowitz BA, Yang JC, Hempstead J, Spector S. Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. Anesthesiology. 1976;44:398\u2013401.","DOI":"10.1097\/00000542-197605000-00008"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, et al. Varenicline: an <i>\u03b1<\/i>4<i>\u03b2<\/i>2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48:3474\u20133477.","DOI":"10.1021\/jm050069n"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist at <i>\u03b1<\/i>4<i>\u03b2<\/i>2 and a full agonist at <i>\u03b1<\/i>7 neuronal nicotinic receptors. Mol Pharmacol. 2006;70:801\u2013805.","DOI":"10.1124\/mol.106.025130"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Grabus SD, Martin BR, Damaj MI. Nicotine physical dependence in the mouse: involvement of the <i>\u03b1<\/i>7 nicotinic receptor subtype. Eur J Pharmacol. 2005;515:90\u201393.","DOI":"10.1016\/j.ejphar.2005.03.044"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Stoker AK, Semenova S, Markou A. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL\/6J and BALB\/cByJ mice. Neuropharmacology. 2008;54:1223\u20131232.","DOI":"10.1016\/j.neuropharm.2008.03.013"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/124\/1\/124_13172FP\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:25:58Z","timestamp":1746087958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/124\/1\/124_13172FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.13172fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"type":"print","value":"1347-8613"},{"type":"electronic","value":"1347-8648"}],"subject":[],"published":{"date-parts":[[2014]]}}}